Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy

An, Myeonghyun; Park, Yae Min; Seo, Jeongduk; Lee, Joonpyo; Jang, Albert Youngwoo; Kang, Woong Chol; Chung, Wook-Jin; Choi, In Suck

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/5Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes

In titles and abstracts

In keywords

In all

The Anatolian Journal of Cardiology

Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy [Anatol J Cardiol]

Anatol J Cardiol. 2023; 27(10): 608-610 | DOI: 10.14744/AnatolJCardiol.2023.3474

Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy

Myeonghyun An, Yae Min Park, Jeongduk Seo, Joonpyo Lee, Albert Youngwoo Jang, Woong Chol Kang, Wook-Jin Chung, In Suck Choi
Division of Cardiology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea

Myeonghyun An, Yae Min Park, Jeongduk Seo, Joonpyo Lee, Albert Youngwoo Jang, Woong Chol Kang, Wook-Jin Chung, In Suck Choi. Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy. Anatol J Cardiol. 2023; 27(10): 608-610

Corresponding Author: Yae Min Park
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar